Intrahepatic Administration of Liposomal Amphotericin B (Ambisome) for the Management of a Liver Abscess from Candida albicans in a Preterm Infant

Antimicrob Agents Chemother. 2018 Nov 26;62(12):e01239-18. doi: 10.1128/AAC.01239-18. Print 2018 Dec.

Abstract

Hepatic fungal abscesses are rare in the neonatal period and often constitute a severe complication of the catheterization of the umbilical vessels. Such life-threatening lesions are observed more frequently in preterm than in other newborn infants and the optimal treatment remains uncertain. We present the case of a preterm neonate, who developed an intrahepatic lesion due to parenteral extravasation, successively contaminated by Candida albicans Despite the maximal pharmacological therapies, the treatment that led to the definitive resolution of the abscess was the placement of surgical drainage followed by the direct intralesional administration of liposomal amphotericin B (Ambisome), never described in neonates in the literature, which turned out to be a safe and effective approach.

Keywords: Candida albicans; liposomal amphotericin B; liver abscess.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Candida albicans / drug effects*
  • Candida albicans / growth & development
  • Candida albicans / pathogenicity
  • Candidiasis / drug therapy*
  • Candidiasis / microbiology
  • Candidiasis / pathology
  • Candidiasis / surgery
  • Catheters, Indwelling
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Injections, Intralesional
  • Intensive Care Units, Neonatal
  • Liver / drug effects
  • Liver / microbiology
  • Liver / pathology
  • Liver / surgery
  • Liver Abscess / drug therapy*
  • Liver Abscess / microbiology
  • Liver Abscess / pathology
  • Liver Abscess / surgery
  • Treatment Outcome

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B